German healthcare company Fresenius SE & Co. KGAA has accelerated the pace of its M&A activity since promoting its CFO Stephan Sturm to the CEO role in July last year.
Following its acquisition of Spanish private hospital group Quironsalud for $6.1bn in 2016, it has confirmed it is buying US...




![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
